Enhancement of Voltage-Gated K⁺ Channels and Depression of Voltage-Gated Ca²⁺ Channels Are Involved in Quercetin-Induced Vasorelaxation in Rat Coronary Artery

Abstract

Quercetin is one of the most common flavonoids in the human daily diet. Its affects the coronary artery, especially L-type voltage-gated Ca²⁺ channels and voltage-gated K⁺ channels in the arterial smooth muscle cells, which are poorly understood. The present experiments were designed to study the myogenic effect of quercetin and its possible underlying mechanisms in the rat coronary artery. A wire myograph was used to observe the myogenic effects. Arterial smooth muscle cells were freshly isolated from the rat coronary artery and the intracellular free Ca²⁺ concentration was measured with molecular probe fluo-4-AM. The effects of quercetin on L-type voltage-gated Ca²⁺ channels and voltage-gated K⁺ channels were studied using a whole-cell patch clamp. Quercetin (3–30 µM) produced a depression and relaxation on the contraction induced by KCl or the thromboxane A2 analog 9,11-Dideoxy-9α,11α-methanoepoxy prostaglandin F _2α . The vasorelaxation was attenuated by 4-aminopyridine, a specific voltage-gated K⁺ channel inhibitor, but was not affected by the NG-nitro-L-arginine methylester ester (a nitric oxide synthesis inhibitor), glibenclamide (a ATP-activated K⁺ channel inhibitor), iberiotoxin (a Ca²⁺-activated K⁺ channel inhibitor), BaCl₂ (an inward rectifier K⁺ channel inhibitor), or by endothelium denudation. At the same concentrations, quercetin reduced the KCl-induced elevation of the intracellular free Ca²⁺ concentration, inhibited the inward Ca²⁺ currents through L-type voltage-gated Ca²⁺ channels, and increased the outward K⁺ currents through voltage-gated K⁺ channels in the rat coronary artery smooth muscle cells. Collectively, our results demonstrate that quercetin possesses vasospasmolytic effects in RCA and suggest that depression of the Ca²⁺ influx through L-type voltage-gated Ca²⁺ channels and augmentation of voltage-gated K⁺ channel activity in the myocytes may underlie coronary relaxation.

Key words

quercetin - rat coronary artery - vasorelaxation - L-type voltage-gated calcium channels - voltage-gated potassium channels

• References

• 1 Erlund I, Freese R, Marniemi J, Hakala P, Alfthan G. Bioavailability of quercetin from berries and the diet. Nutr Cancer 2006; 54: 13-17
• 2 Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76: 560-568
• 3 Zamora-Ros R, Jimenez C, Cleries R, Agudo A, Sanchez MJ, Sanchez-Cantalejo E, Molina-Montes E, Navarro C, Chirlaque MD, Maria Huerta J, Amiano P, Redondo ML, Barricarte A, Gonzalez CA. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology 2013; 24: 726-733
• 4 Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012; 83: 6-15
• 5 de Whalley CV, Rankin SM, Hoult JR, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990; 39: 1743-1750
• 6 Mann GE, Rowlands DJ, Li FY, de Winter P, Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 2007; 75: 261-274
• 7 Ertug PU, Aydinoglu F, Goruroglu Ozturk O, Singirik E, Ogulener N. Comparative study of the quercetin, ascorbic acid, glutathione and superoxide dismutase for nitric oxide protecting effects in mouse gastric fundus. Eur J Pharmacol 2013; 698: 379-387
• 8 Lopez-Lopez G, Moreno L, Cogolludo A, Galisteo M, Ibarra M, Duarte J, Lodi F, Tamargo J, Perez-Vizcaino F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol Pharmacol 2004; 65: 851-859
• 9 Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000; 72: 1150-1155
• 10 Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One 2013; 8: e63784
• 11 Das DK, Chakraborty A, Sinha M, Manna K, Mukherjee D, Chakraborty A, Bhattacharjee S, Dey S. Modulatory role of quercetin against gamma radiation-mediated biochemical and morphological alterations of red blood cells. Int J Radiat Biol 2013; 89: 471-481
• 12 Liu CJ, Lin JY. Anti-inflammatory effects of phenolic extracts from strawberry and mulberry fruits on cytokine secretion profiles using mouse primary splenocytes and peritoneal macrophages. Int Immunopharmacol 2013; 16: 165-170
• 13 Moon J, Lee SM, Do HJ, Cho Y, Chung JH, Shin MJ. Quercetin up-regulates LDL receptor expression in HepG2 cells. Phytother Res 2012; 26: 1688-1694
• 14 Shen Y, Ward NC, Hodgson JM, Puddey IB, Wang Y, Zhang D, Maghzal GJ, Stocker R, Croft KD. Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1. Free Radic Biol Med 2013; 65: 908-915
• 15 Bardy G, Virsolvy A, Quignard JF, Ravier MA, Bertrand G, Dalle S, Cros G, Magous R, Richard S, Oiry C. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol 2013; 169: 1102-1113
• 16 Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 2002; 35: 119-124
• 17 Kressler J, Millard-Stafford M, Warren GL. Quercetin and endurance exercise capacity: a systematic review and meta-analysis. Med Sci Sports Exerc 2011; 43: 2396-2404
• 18 Jalili T, Carlstrom J, Kim S, Freeman D, Jin H, Wu TC, Litwin SE, David Symons J. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol 2006; 47: 531-541
• 19 Jin HB, Yang YB, Song YL, Zhang YC, Li YR. Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats. Mol Biol Rep 2012; 39: 11005-11009
• 20 Annapurna A, Reddy CS, Akondi RB, Rao SR. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2009; 61: 1365-1374
• 21 Bartekova M, Carnicka S, Pancza D, Ondrejcakova M, Breier A, Ravingerova T. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Can J Physiol Pharmacol 2010; 88: 465-471
• 22 Lodi F, Jimenez R, Moreno L, Kroon PA, Needs PW, Hughes DA, Santos-Buelga C, Gonzalez-Paramas A, Cogolludo A, Lopez-Sepulveda R, Duarte J, Perez-Vizcaino F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 2009; 204: 34-39
• 23 Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 2008; 88: 1018-1025
• 24 Pashevin DA, Tumanovska LV, Dosenko VE, Nagibin VS, Gurianova VL, Moibenko AA. Antiatherogenic effect of quercetin is mediated by proteasome inhibition in the aorta and circulating leukocytes. Pharmacol Rep 2011; 63: 1009-1018
• 25 Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 2003; 301: 1069-1078
• 26 Oak MH, El Bedoui J, Schini-Kerth VB. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005; 16: 1-8
• 27 Perez-Vizcaino F, Ibarra M, Cogolludo AL, Duarte J, Zaragoza-Arnaez F, Moreno L, Lopez-Lopez G, Tamargo J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther 2002; 302: 66-72
• 28 Ibarra M, Perez-Vizcaino F, Cogolludo A, Duarte J, Zaragoza-Arnaez F, Lopez-Lopez JG, Tamargo J. Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med 2002; 68: 307-310
• 29 Ajay M, Achike FI, Mustafa AM, Mustafa MR. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2006; 73: 1-7
• 30 Xiong Z, Sperelakis N. Regulation of L-type calcium channels of vascular smooth muscle cells. J Mol Cell Cardiol 1995; 27: 75-91
• 31 Saponara S, Sgaragli G, Fusi F. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels. Eur J Pharmacol 2008; 598: 75-80
• 32 Fusi F, Saponara S, Pessina F, Gorelli B, Sgaragli G. Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena. Eur J Nutr 2003; 42: 10-17
• 33 Saponara S, Sgaragli G, Fusi F. Quercetin as a novel activator of L-type Ca(2+) channels in rat tail artery smooth muscle cells. Br J Pharmacol 2002; 135: 1819-1827
• 34 Martin P, Rebolledo A, Palomo AR, Moncada M, Piccinini L, Milesi V. Diversity of potassium channels in human umbilical artery smooth muscle cells: a review of their roles in human umbilical artery contraction. Reprod Sci 2013;
• 35 Dick GM, Tune JD. Role of potassium channels in coronary vasodilation. Exp Biol Med (Maywood) 2010; 235: 10-22
• 36 Cogolludo A, Frazziano G, Briones AM, Cobeno L, Moreno L, Lodi F, Salaices M, Tamargo J, Perez-Vizcaino F. The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation. Cardiovasc Res 2007; 73: 424-431
• 37 Iozzi D, Schubert R, Kalenchuk VU, Neri A, Sgaragli G, Fusi F, Saponara S. Quercetin relaxes rat tail main artery partly via a PKG-mediated stimulation of KCa 1.1 channels. Acta Physiol (Oxf) 2013; 208: 329-339
• 38 Berwick ZC, Moberly SP, Kohr MC, Morrical EB, Kurian MM, Dick GM, Tune JD. Contribution of voltage-dependent K⁺ and Ca²⁺ channels to coronary pressure-flow autoregulation. Basic Res Cardiol 2012; 107: 264
• 39 Cogolludo A, Moreno L, Bosca L, Tamargo J, Perez-Vizcaino F. Thromboxane A2-induced inhibition of voltage-gated K⁺ channels and pulmonary vasoconstriction: role of protein kinase Czeta. Circ Res 2003; 93: 656-663
• 40 Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 2001; 89: 146-152
• 41 Ajay M, Gilani AU, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 2003; 74: 603-612
• 42 Nishida S, Satoh H. Role of gap junction involved with endothelium-derived hyperpolarizing factor for the quercetin-induced vasodilatation in rat mesenteric artery. Life Sci 2013; 92: 752-756
• 43 Kaushik D, OʼFallon K, Clarkson PM, Dunne CP, Conca KR, Michniak-Kohn B. Comparison of quercetin pharmacokinetics following oral supplementation in humans. J Food Sci 2012; 77: H231-H238
• 44 Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 2008; 29: 205-217
• 45 Klockner U, Isenberg G. Intracellular pH modulates the availability of vascular L-type Ca2+ channels. J Gen Physiol 1994; 103: 647-663
• 46 White R, Hiley CR. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 1997; 122: 1573-1584